NeurAxis Statistics
Total Valuation
NeurAxis has a market cap or net worth of $23.34 million. The enterprise value is $17.67 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NeurAxis has 9.53 million shares outstanding. The number of shares has increased by 30.12% in one year.
| Current Share Class | 9.53M |
| Shares Outstanding | 9.53M |
| Shares Change (YoY) | +30.12% |
| Shares Change (QoQ) | +14.16% |
| Owned by Insiders (%) | 21.13% |
| Owned by Institutions (%) | 15.97% |
| Float | 7.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.74 |
| Forward PS | 10.44 |
| PB Ratio | 5.78 |
| P/TBV Ratio | 5.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.82 |
| Quick Ratio | 2.61 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -34.10 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -91.69% |
| Return on Invested Capital (ROIC) | -197.25% |
| Return on Capital Employed (ROCE) | -150.42% |
| Revenue Per Employee | $153,216 |
| Profits Per Employee | -$371,644 |
| Employee Count | 21 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 5.74 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.97% in the last 52 weeks. The beta is 3.11, so NeurAxis's price volatility has been higher than the market average.
| Beta (5Y) | 3.11 |
| 52-Week Price Change | -23.97% |
| 50-Day Moving Average | 2.54 |
| 200-Day Moving Average | 2.50 |
| Relative Strength Index (RSI) | 41.89 |
| Average Volume (20 Days) | 58,563 |
Short Selling Information
The latest short interest is 28,410, so 0.30% of the outstanding shares have been sold short.
| Short Interest | 28,410 |
| Short Previous Month | 18,996 |
| Short % of Shares Out | 0.30% |
| Short % of Float | 0.40% |
| Short Ratio (days to cover) | 0.35 |
Income Statement
In the last 12 months, NeurAxis had revenue of $3.22 million and -$7.80 million in losses. Loss per share was -$1.05.
| Revenue | 3.22M |
| Gross Profit | 2.72M |
| Operating Income | -7.13M |
| Pretax Income | -15.26M |
| Net Income | -7.80M |
| EBITDA | -7.10M |
| EBIT | -7.13M |
| Loss Per Share | -$1.05 |
Full Income StatementBalance Sheet
The company has $5.99 million in cash and $410,478 in debt, giving a net cash position of $5.58 million or $0.59 per share.
| Cash & Cash Equivalents | 5.99M |
| Total Debt | 410,478 |
| Net Cash | 5.58M |
| Net Cash Per Share | $0.59 |
| Equity (Book Value) | 4.25M |
| Book Value Per Share | 0.43 |
| Working Capital | 4.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.22 million and capital expenditures -$29,656, giving a free cash flow of -$6.25 million.
| Operating Cash Flow | -6.22M |
| Capital Expenditures | -29,656 |
| Free Cash Flow | -6.25M |
| FCF Per Share | -$0.66 |
Full Cash Flow StatementMargins
Gross margin is 84.47%, with operating and profit margins of -221.62% and -222.91%.
| Gross Margin | 84.47% |
| Operating Margin | -221.62% |
| Pretax Margin | -222.91% |
| Profit Margin | -222.91% |
| EBITDA Margin | -220.52% |
| EBIT Margin | -221.62% |
| FCF Margin | n/a |
Dividends & Yields
NeurAxis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.12% |
| Shareholder Yield | -30.12% |
| Earnings Yield | -33.57% |
| FCF Yield | -26.89% |
Analyst Forecast
The average price target for NeurAxis is $7.00, which is 185.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 185.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |